Source document or public record

FDA 510(k) K240867 — cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems

FDA 510(k) index record K240867. Device: cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems. Applicant as listed: Roche Molecular Systems, Inc.. Decision date: 2025-02-11.

OtherU.S. Food and Drug Administration (FDA)2025-02-11

Source

"device_name": "cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K240867.

Device name: cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems. Applicant as listed: Roche Molecular Systems, Inc..

Decision date: 2025-02-11. Decision wording: Substantially Equivalent.

Product code: QQX. Regulation: 21 CFR 866.3981. Medical specialty: Microbiology.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.